California Employment News: Top Developments in Wage and Hour Law for 2024 (Podcast)
California Employment News: Top Developments in Wage and Hour Law for 2024
Law School Toolbox Podcast Episode 395: Listen and Learn -- Evidence: Special Privileges
The Labor Law Insider: Non-Disclosure and Non-Disparagement Agreements under Fire: A New Board Decision and a New General Counsel Memorandum, Part II
The Labor Law Insider: Non-Disclosure and Non-Disparagement Agreements under Fire: A New Board Decision and a New General Counsel Memorandum
Employment Law Now VII-127-Interview with NLRB General Counsel Abruzzo on Invalidating Severance Agreement Provisions
Chambliss Update – NLRB Decision Alters Landscape for Employee Severance Agreements
DE Under 3: New NLRB Decision Prohibits Virtually All Employment Confidentiality and Non-Disparagement Clauses, Nationwide
#WorkforceWednesday: Spilling Secrets: Employers - Train on Trade Secrets - Employment Law This Week®
What Can Squid Game Teach Us About Confidentiality Agreements and Restrictive Covenants? - Hiring to Firing Podcast
California Employment News: The Erosion of Confidentiality Clauses in Settlement Agreements
#WorkforceWednesday: NLRB Outlook, NY Whistleblower Protections Take Effect, DOJ to Focus on Cyber-Fraud - Employment Law This Week®
Monthly Minute | Trade Secret Protection Best Practices–Employment and Confidentiality Agreements
SaaS Transactions: Data-Related Issues in SaaS Agreements - Tech Podcast
#WorkforceWednesday: Sick Leave in New York, California Law Update, and Oregon’s Workplace Fairness Act Takes Effect
Developments in New York State Labor and Employment Law – What You Need to Know in 2020
Non-Competes Are Not So Bad! The Current Law and Why Proposed Legislation in Congress is an Overreaction
Nota Bene Episode 37: How to Prevent or Defend Against Business Crimes with Chuck Kreindler
III-41- Things That Make You Go “Hmmm” in Employment Law
II-35- The New Sexual Harassment Training/Policy Requirements in New York State and New York City
Goodwin’s 337 Quarterly Insider remains the premiere publicly available source for keeping up to date on all meaningful decisions coming out of the Commission. Please find below Goodwin’s insights on the months of April, May,...more
In a complaint filed June 14, 2016, Janssen Biotech Inc. seeks a preliminary injunction that would bar Celltrion and Hospira from selling the biosimilar version of Remicade® (infliximab) that received FDA approval April 2016,...more